Synaptogenix Inc (SNPX) Actualités

Form 8-K - Current report

Synaptogenix Board of Directors Forms Special Committee to Explore Value Creation Opportunities Utilizing Balance Sheet Strength

Synaptogenix Board of Directors Forms Special Committee to Explore Value Creation Opportunities Utilizing Balance Sheet Strength PR Newswire NEW...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form DEF 14A - Other definitive proxy statements

Form ARS - Annual Report to Security Holders

Form PRE 14A - Other preliminary proxy statements

Form EFFECT - Notice of Effectiveness

Form S-3 - Registration statement under Securities Act of 1933

Form 8-K - Current report

Form D - Notice of Exempt Offering of Securities

Form 8-K - Current report

Form 8-K - Current report

Synaptogenix Announces $5.0 Million Financing

Synaptogenix Announces $5.0 Million Financing PR Newswire NEW YORK, Sept. 11, 2024 NEW YORK, Sept. 11, 2024 /PRNewswire/ -- Synaptogenix, Inc...

Form 8-K - Current report